Eagle Ridge Investment Management raised its stake in shares of Stryker Corporation (NYSE:SYK) by 1.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 47,610 shares of the medical technology company’s stock after acquiring an additional 621 shares during the quarter. Eagle Ridge Investment Management’s holdings in Stryker Corporation were worth $6,762,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Bollard Group LLC boosted its stake in Stryker Corporation by 0.4% during the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after acquiring an additional 3 shares during the last quarter. Blue Chip Partners Inc. boosted its stake in Stryker Corporation by 0.3% during the 2nd quarter. Blue Chip Partners Inc. now owns 1,781 shares of the medical technology company’s stock valued at $247,000 after acquiring an additional 6 shares during the last quarter. Guardian Life Insurance Co. of America boosted its stake in Stryker Corporation by 0.8% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock valued at $158,000 after acquiring an additional 9 shares during the last quarter. FineMark National Bank & Trust boosted its stake in Stryker Corporation by 0.4% during the 2nd quarter. FineMark National Bank & Trust now owns 3,878 shares of the medical technology company’s stock valued at $538,000 after acquiring an additional 15 shares during the last quarter. Finally, Lee Danner & Bass Inc. boosted its stake in Stryker Corporation by 0.8% during the 2nd quarter. Lee Danner & Bass Inc. now owns 1,966 shares of the medical technology company’s stock valued at $273,000 after acquiring an additional 16 shares during the last quarter. Hedge funds and other institutional investors own 74.00% of the company’s stock.

A number of research firms have commented on SYK. SunTrust Banks, Inc. reiterated a “buy” rating and set a $161.00 price objective on shares of Stryker Corporation in a research note on Monday, October 2nd. Stifel Nicolaus increased their target price on shares of Stryker Corporation from $151.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Oppenheimer Holdings, Inc. set a $156.00 target price on shares of Stryker Corporation and gave the stock a “hold” rating in a report on Monday. Canaccord Genuity increased their target price on shares of Stryker Corporation from $155.00 to $162.00 and gave the stock a “buy” rating in a report on Friday, October 27th. Finally, BidaskClub cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Stryker Corporation currently has a consensus rating of “Hold” and a consensus price target of $151.52.

In related news, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the transaction, the insider now directly owns 8,983 shares in the company, valued at approximately $1,313,853.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The disclosure for this sale can be found here. Insiders own 7.40% of the company’s stock.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.50 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.39 earnings per share.

COPYRIGHT VIOLATION NOTICE: “Stryker Corporation (SYK) Shares Bought by Eagle Ridge Investment Management” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://theolympiareport.com/2017/11/02/stryker-corporation-syk-shares-bought-by-eagle-ridge-investment-management.html.

Stryker Corporation Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.